IMMUNOREACTIVE INTERLEUKIN-6 AND C-REACTIVE PROTEIN IN PLASMA CELL DISORDERS
- 1 August 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (4) , 883-884
- https://doi.org/10.1111/j.1365-2141.1994.tb06765.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Serum immunoreactive interleukin‐6 and C‐reactive protein levels in patients with multiple myeloma at diagnosisBritish Journal of Haematology, 1994
- Interleukin‐6 serum levels in patients with multiple myelomaBritish Journal of Haematology, 1994
- Plasma cell labeling index, beta 2-microglobulin, and C-reactive protein: what is the best combination for myeloma prognosis? [letter; comment]Blood, 1993
- Radioimmunoassay for the measurement of serum IL‐6 and its correlation with tumour cell mass parameters in multiple myelomaAmerican Journal of Hematology, 1992
- The Use of a Commercially Available Immunoassay to Determine the Level of Interleukin-6 in the Serum of Patients with MyelomaLeukemia & Lymphoma, 1991
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989